Cargando…

Rapamycin for the aging skin

Detalles Bibliográficos
Autor principal:	Blagosklonny, Mikhail V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949048/ https://www.ncbi.nlm.nih.gov/pubmed/31895693 http://dx.doi.org/10.18632/aging.102664

Ejemplares similares

As predicted by hyperfunction theory, rapamycin treatment during development extends lifespan
por: Blagosklonny, Mikhail V.
Publicado: (2022)

As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Progeria, rapamycin and normal aging: recent breakthrough
por: Blagosklonny, Mikhail V.
Publicado: (2011)

Cell senescence, rapamycin and hyperfunction theory of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Rapamycin extends life- and health span because it slows aging
por: Blagosklonny, Mikhail V.
Publicado: (2013)

Cancer prevention with rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Rapamycin for longevity: opinion article
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Rapamycin, proliferation and geroconversion to senescence
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Does rapamycin slow down time?
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Fasting and rapamycin: diabetes versus benevolent glucose intolerance
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
por: Blagosklonny, Mikhail V.
Publicado: (2012)

DNA- and telomere-damage does not limit lifespan: evidence from rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2021)

Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Rapamycin suppresses brain aging in senescence-accelerated OXYS rats
por: Kolosova, Nataliya G., et al.
Publicado: (2013)

Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging
por: Leontieva, Olga V., et al.
Publicado: (2012)

While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts
por: Leontieva, Olga V., et al.
Publicado: (2017)

Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet
por: Leontieva, Olga V, et al.
Publicado: (2014)

Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin
por: Leontieva, Olga V., et al.
Publicado: (2011)

Rapamycin – “One size does not fit all”
por: Kallijärvi, Jukka, et al.
Publicado: (2019)

Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
por: Komarova, Elena A., et al.
Publicado: (2012)

Validation of anti-aging drugs by treating age-related diseases
por: Blagosklonny, Mikhail V.
Publicado: (2009)

Disease or not, aging is easily treatable
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Damage-induced aging and perpetual motion
por: Blagosklonny, Mikhail V
Publicado: (2013)

From rapalogs to anti-aging formula
por: Blagosklonny, Mikhail V.
Publicado: (2017)

Are menopause, aging and prostate cancer diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet
por: Leontieva, O V, et al.
Publicado: (2013)

How to save Medicare: the anti-aging remedy
por: Blagosklonny, Mikhail V.
Publicado: (2012)

The hyperfunction theory of aging: three common misconceptions
por: Blagosklonny, Mikhail V.
Publicado: (2021)

Anti-aging: senolytics or gerostatics (unconventional view)
por: Blagosklonny, Mikhail V.
Publicado: (2021)

New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53(−/−) mice by delaying carcinogenesis
por: Comas, Maria, et al.
Publicado: (2012)

Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
por: Leontieva, O V, et al.
Publicado: (2014)

Rapamycin increases breast tumor burden in young wheel-running mice
por: Wang, Juan, et al.
Publicado: (2019)

Answering the ultimate question “What is the Proximal Cause of Aging?”
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Selective anti-cancer agents as anti-aging drugs
por: Blagosklonny, Mikhail V
Publicado: (2013)

From causes of aging to death from COVID-19
por: Blagosklonny, Mikhail V.
Publicado: (2020)

Molecular damage in cancer: an argument for mTOR-driven aging
por: Blagosklonny, Mikhail V.
Publicado: (2011)

Linking calorie restriction to longevity through sirtuins and autophagy: any role for TOR
por: Blagosklonny, M V
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2ie3ocqnvrbjirearohmsi428j